(19)
(11) EP 3 620 787 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.02.2022 Bulletin 2022/08

(45) Mention of the grant of the patent:
09.02.2022 Bulletin 2022/06

(21) Application number: 19204276.0

(22) Date of filing: 26.01.2011
(51) International Patent Classification (IPC): 
G01N 29/00(2006.01)
 B41J 2/045(2006.01)
(52) Cooperative Patent Classification (CPC):
B41J 2/04536; B41J 2/04575; B41J 2/04596

(54)

FOCUS-ACTIVATED ACOUSTIC EJECTION

FOKUSAKTIVIERTE AKUSTIKAUSGABE

ÉJECTION ACOUSTIQUE ACTIVÉE PAR FOCALISATION

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 26.01.2010 US 29841510 P

(43) Date of publication of application:
11.03.2020 Bulletin 2020/11

(60) Divisional application:
22151049.8

(62) Application number of the earlier application in accordance with Art. 76 EPC:
11737577.4 / 2529213

(73) Proprietor: Labcyte Inc.
San Jose, CA 95134 (US)

(72) Inventor:
  • ELLSON, Richard N.
    San Jose, CA 95134 (US)

(74) Representative: Miller Sturt Kenyon 
9 John Street
London WC1N 2ES
London WC1N 2ES (GB)


(56) References cited: : 
US-A1- 2004 120 855
US-A1- 2006 071 983
US-B2- 7 354 141
 US-A1- 2005 061 078
US-A1- 2006 156 797
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).